RMTI Rockwell Medical Inc.

4.65
+0.4  (+9%)
Previous Close 4.25
Open 4.25
Price To Book 21.14
Market Cap 264946100
Shares 56,977,656
Volume 348,635
Short Ratio
Av. Daily Volume 278,578

SEC filingsSee all SEC filings

  1. 8-K - Current report 19612120
  2. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19572491
  3. 8-K - Current report 19513915
  4. EFFECT - Notice of Effectiveness 181215315
  5. 8-K - Current report 181209090

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved January 26, 2015.
Soluble Ferric Pyrophosphate
Iron deficiency
NDA filing due 4Q 2018.
IV Triferic
Iron deficiency (Kidney disease)

Latest News

  1. Rockwell Medical, Inc. to Present at 2019 BIO CEO & Investor Conference
  2. Rockwell Medical, Inc. (NASDAQ:RMTI): What Does Its Beta Value Mean For Your Portfolio?
  3. The Zacks Analyst Blog Highlights: Barclays, Rockwell Medical, NextEra, Belmond and Shaw Communications
  4. 7 Hot Momentum Stocks to Watch in 2019
  5. Rockwell Medical, Inc. to Present at Biotech Showcase™ 2019
  6. Edited Transcript of RMTI earnings conference call or presentation 9-Nov-18 1:30pm GMT
  7. 5 Beaten-Down Medical Product Stocks to Rebound in 2019
  8. Report: Developing Opportunities within Eaton Vance, IDT, Hemispherx BioPharma, Edgewell Personal Care, Rockwell Medical, and Avadel Pharmaceuticals — Future Expectations, Projections Moving into 2018
  9. Rockwell Medical, Inc. Appoints New Vice President, Operations
  10. Rockwell Medical, Inc. Appoints New Vice President, Marketing
  11. Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates
  12. Rockwell Medical: 3Q Earnings Snapshot
  13. Rockwell Medical, Inc. Reports Third Quarter 2018 Financial Results
  14. Analysts Estimate Rockwell Medical (RMTI) to Report a Decline in Earnings: What to Look Out for
  15. Rockwell Medical Appoints New Chief Financial Officer
  16. Rockwell Medical Schedules Third Quarter 2018 Conference Call
  17. Rockwell Medical Announces Financing Transaction
  18. Rockwell Medical Provides Update on IV Triferic

SEC Filings

  1. 8-K - Current report 19612120
  2. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 19572491
  3. 8-K - Current report 19513915
  4. EFFECT - Notice of Effectiveness 181215315
  5. 8-K - Current report 181209090
  6. CT ORDER - Confidential treatment order 181194415
  7. S-3 - Registration statement under Securities Act of 1933 181190171
  8. 8-K - Current report 181174618
  9. 10-Q - Quarterly report [Sections 13 or 15(d)] 181173964
  10. 8-K - Current report 181157441